Spelling suggestions: "subject:"cysteineprotease"" "subject:"cysteinprotease""
1 |
Ectopic expression of sweet potato cysteine protease SPCP2 promotes earlier flowering and enhances drought stress tolerance.Lin, Chia-hung 17 June 2010 (has links)
Sweet potato SPCP2 is a full-length cDNA isolated from senescent leaves and encodes a putative papain-like cysteine protease. The SPCP2 contained 1101 nucleotides (366 amino acids) in its open reading frame, and exhibited high amino acid sequence identities (ca. 68% to 83%) with plant cysteine proteases, including Actinidia deliciosa, Arabidopsis thaliana, Brassica oleracea, Phaseolus vulgaris, Pisum sativa, Vicia faba, Vicia sativa and Vigna mungo. SPCP2 gene expression was enhanced significantly in natural senescent leaves and in sprouting storage root. Transgenic Arabidopsis plants with ectopic constitutive SPCP2 expression showed earlier floral transition from vegetative to reproductive growth, reduced rosette leaves when flowering, enhanced germination percentage of transgenic progeny seeds in salt-containing MS medium, higher Fv/Fm value, higher relative water content and enhanced tolerance during drought treatment. Based on these results, we conclude that sweet potato papain-like cysteine protease, SPCP2, is a functional gene, and its expression causes altered developmental characteristics and enhances drought and salt stress responses in transgenic Arabidopsis plants.
|
2 |
Cystatin C functions in vitro and in vivo studies on target enzyme inhibition by cystatin C variants and cystatin C deficient mice /Håkansson, Katarina. January 1998 (has links)
Thesis (doctoral)--Lund University, 1998. / Added t.p. with thesis statement inserted.
|
3 |
Cystatin C functions in vitro and in vivo studies on target enzyme inhibition by cystatin C variants and cystatin C deficient mice /Håkansson, Katarina. January 1998 (has links)
Thesis (doctoral)--Lund University, 1998. / Added t.p. with thesis statement inserted.
|
4 |
Mechanisms of cell death in cerebellar granule neuronesSingh, Shweta January 2001 (has links)
No description available.
|
5 |
Design and Synthesis of Anti Cancer Agents that Inhibit Cysteine Proteases, Limit Oxidative Stress or Terminate Proliferation of BCR-ABL Expressing CellsGurjar, Purujit 02 October 2018 (has links)
No description available.
|
6 |
CHARACTERIZATION OF PHYTOCYSTATIN-LIKE CYSTEINE PROTEASE INHIBITORS OF TRICHOMONAS VAGINALISFaucher, Ryan Michael John 01 January 2017 (has links)
Trichomoniasis is a common STD caused by the parasitic protozoan Trichomonas vaginalis. The parasite is estimated to have infected roughly 3.7 million Americans. Complications from trichomoniasis can lead to cervical cancer in women and prostate cancer in men. One of the mechanisms of the parasite employs is using cysteine proteases to break down the cellular matrix of its host. However, three endogenous phytocystatin-like protease inhibitors have been found within the parasite’s genome. By recombinantly expressing these cystatins we have been able to test their ability to inhibit cysteine proteases such as papain and those found in T. vaginalis to find their effectiveness. By characterizing these inhibitors, it appears that they are effective at reducing the ability of T. vaginalis cysteine proteases and thus could be useful against the pathogenicity of the parasite.
|
7 |
Promoter Deletion Analysis of Xylem Cysteine Protease 2 (XCP2) in Arabidopsis thalianaPetzold, Herman Earl III 01 June 2007 (has links)
The process of xylem tracheary element differentiation involves the coordination of vascular cambium activity, cell fate determination, cell expansion/elongation, secondary wall synthesis, programmed cell death, and cellular autolysis. The end result of tracheary element differentiation is a cellular corpse lacking a protoplast and consisting of a thickened cell wall composed mostly of lignin and cellulose. Little is known about the genetic mechanisms regulating the process of tracheary element differentiation. XCP2 expression localizes to tracheary elements according to two independent methods of analysis: promoter reporter experiments and immunogold localization by electron microscopy. XCP2 may be involved in catalyzing the degeneration of the protoplast during the final autolytic stages of tracheary element differentiation. To this date XCP2 function has not been directly demonstrated. In principle, any tracheary element-specific markers can be linked to upstream regulatory genes with roles in tracheary element differentiation. To develop the XCP2 promoter as a tool for identification of transacting factors, a promoter deletion analysis was carried out. Utilizing information from 5â and 3â deletion constructs, a 70-bp region upstream of the XCP2 translational start site is both necessary and sufficient for TE-specific expression of the UidA reporter gene. Mutational analysis of the ACTTTA element at position -113-bp strongly suggests it is a cis element required for XCP2 expression. In silico analysis of an 18-bp promoter region located within 200-bp of the translation start site and including the ACTTTA element revealed high indentity shared between xylem-specific XCP2 homologs from Zinnia elegans, Populus trichocarpa, and XCP1 from Arabidopsis thaliana. / Master of Science
|
8 |
Studies on secreted cysteine proteases of Streptococcus pyogenes : IdeS and SpeBVindebro, Reine January 2014 (has links)
The pathogen Streptococcus pyogenes is a significant cause of human morbidity and mortality. Most of the work in this thesis is focused on streptococcal virulence factor IdeS, but the thesis also features work on SpeB, another streptococcal virulence factor. Both IdeS and SpeB are secreted cysteine proteases and both have previously been shown to degrade human IgG. IgG is the only known substrate for IdeS while SpeB is a more promiscuous protease with a larger number of identified substrates. A significant part of the data presented in this thesis is the result of designing and optimizing methods to detect and accurately measure the proteolytic degradation of IgG. Methods aimed at measuring the binding interactions between enzyme and substrate have also been frequently utilized. I show that IdeS is a monomeric protease, as opposed to previously published data that suggested it to be dimeric. IdeS cleaves the two heavy chains of IgG in a two-step reaction and I demonstrate that the first cleavage is magnitudes faster than the second one. This means that IdeS is a more efficient enzyme than previously thought. The difference in rate cannot completely be explained by a loss of affinity between IdeS and IgG after the cleavage of the first heavy chain. The velocity of IdeS is further increased by the presence of human Cystatin C, via an unknown mechanism. Cystatin C is normally a protease inhibitor and it having an opposite effect is puzzling.The synthesis and evaluation of novel inhibitors are also described. Peptide analogues mimicking the sequence surrounding the scissile bond on IgG - with an amino acid replaced with a more rigid motif - act as specific, but low-affinity, inhibitors of IdeS. The peptide analogues’ inhibitory capacity for SpeB and papain was also assayed.When it comes to SpeB, I show that it does not have IgG as a substrate under physiological conditions, in contrast to what was previously thought. This thesis does not only present findings on the IgG degrading capacity of IdeS and SpeB but also include data on fundamental enzymatic properties for these proteases.
|
9 |
Estudos estruturais e funcionais da Xylellaína, uma cisteíno protease da bactéria Xylella fastidiosa / Structural and functional studies about Xylellain, the cysteine protease from bacteriumFaro, Aline Regis 16 July 2008 (has links)
A Xylella fastidiosa é uma bactéria gram-negativa que infecta o xilema das plantas causando muitas vezes a maturação precoce e a diminuição dos frutos. Ela é responsável por importantes perdas na economia, no Brasil é a causadora de doenças de Citrus Variegated Chlorosis (CVC) e a da doença de Pierce nos Estados Unidos. As proteases desempenham funções vitais no ciclo de vida de muitos parasitas, muitas estão envolvidas em processos infecciosos, a Xylellaína é uma cisteíno protease que é diferentemente expressa em cepas patogênicas a não patogênica. A compreensão de seu mecanismo catalítico, através do estudo da sua estrutura e função, pode ajudar no planejamento de inibidores seletivos, potenciais agentes contra as doenças fitopatológicas ocasionadas pela X. fastidiosa. Sua estrutura molecular foi elucidada no Laboratório de Cristalografia de Proteínas e Biologia Estrutural do Instituto de Física de São Carlos (USP), estudos estruturais mostraram que a proteína se apresenta na forma de uma pró-proteína, pois está inativa devido a uma pró-região que bloqueia o sítio catalítico. Também foi verificada a presença de um nucleotídeo na estrutura da Xylellaína próximo a pró-região, como hipótese foi considerada a relação entre o nucleotídeo e o mecanismo de ativação da proteína. A influência do nucleotídeo na atividade funcional da enzima foi constatada através da comparação de ensaios enzimáticos entre a enzima nativa e mutantes. As mutações foram planejadas com a intenção de ocasionar a desestabilização do nucleotídeo, por isso foram mutados os resíduos da pró-região que interagem diretamente com o ele. As mutações foram Fenilalanina 45 (F45), Arginina 43 (R43) e F45/R43, todos os resíduos foram mutados para Alaninas (A). Os resultados mostraram que os valores de Km obtidos para a proteína nativa e suas mutantes apresentaram consideráveis alterações quando comparado entre eles, esse efeito não foi percebido para a eficiência catalítica. Conclui-se que as mutações pouco alteraram a capacidade da enzima converter o subsrato em produto, mas houve significantes alterações no reconhecimento do substrato. Esse resultado corrobora com a hipótese de que a existência do nucleotídeo está relacionada com o mecanismo de ativação da proteína. / Xylella fastidiosa is a Gram-negative bacterium which infects the plant xylem system causing in many cases precocious maturation and diminution of fruits. It is responsible for economically important plant diseases, such as the Citrus Variegated Chlorosis (CVC). Proteases might be involved in the infection process by disrupting plant tissue. Xylellain is a cysteine protease which is differently expressed in strain pathogen and non-pathogen of X. fastidiosa. The 3D structure of xylellain was solved by our group and structural studies show that this protein has a proenzyme form and a ribonucleotideo close to the amine terminal region. Our hypothesis is that protein-nucleotide interactions are related to xylellains activation mechanism. To evaluate the influence of the nucleotide in the functional activity of enzyme, point mutations in aminoacids which interact directly with this ribonucleotide were carried out. The point mutations are phenylalanine 45 (F45) and arginine 43 (R43), individually mutated for alanine (A) residues. One way to quantify the changes caused by the alteration of a nucleotide is the direct comparison between the kinetic enzyme assays of native and mutant proteins. Greater variations between the values of Km than in the values of catalytic efficiency were observed. This suggests that the speed of production varied by enzyme-substrate. However the mutations caused little change on the ability of the protease to catalyze the reaction. This result is in agreement with the hypothesis that the nucleotide provides the structural support for the hinge formation on the N-terminal domain, thus directing the inhibitory peptide inside the active site of the enzyme. Therefore, the nucleotide may be exerting regulatory functions in vivo, possibly in the folding or activation of the protein and performance of catalytic function.
|
10 |
Structural Basis of Caspase-3 Substrate Specificity Revealed by Crystallography, Enzyme Kinetics, and Computational ModelingFang, Bin 01 December 2009 (has links)
Caspase-3 is a cysteine protease that hydrolyzes diverse intracellular proteins during programmed cell death (known as apoptosis). It has been a popular target for drug design against abnormal cell death for more than a decade. No approved caspase based drug, however, is available so far. Therefore, structural insights about the substrate recognition of caspase-3 are needed for the future development of caspase-3 based inhibitors and drugs. In this study, crystal structures of recombinant caspase-3 in complex with seven substrate analog inhibitors, including acetyl (Ac)-DEVD-aldehyde (Cho), Ac-DMQD-Cho, Ac-IEPD-Cho, Ac-YVAD-Cho, Ac-WEHD-Cho, Ac-VDVAD-Cho, and tert-butoxycarbonyl (Boc)-D-fluoromethylketone (Fmk), have been analyzed in combination with enzyme kinetic data and computational models. Seven crystal structures were determined at resolutions of 1.7-2.6Å. The binding conformation of each inhibitor residue at P1-P4 position was analyzed. The negative P1 aspartic acid side chain is exclusively required by the positive S1 pocket of caspase-3. Small hydrophobic P2 residues are preferred by the nonpolar S2 pocket formed by Y204, W206, and F256. Although hydrophilic residues at P3 position tend to fit better, hydrophobic residues also can be accommodated by the plastic S3 pocket. Two substrate binding sites were found in the S4 pocket, one formed by main chain atoms of F250 and side chain atoms of N208 and the other formed by aromatic side chains of W206 and W214. These two binding sites are responsible for the binding of hydrophilic and hydrophobic P4 residues, respectively. Furthermore, the S5 subsite of caspase-3 formed by side chains of F250 and F252 was discovered. It stabilizes hydrophobic P5 residues on the substrates by an induced fit mechanism. Computational studies were performed to help improve prediction of protein structures and protein-ligand interactions. Based on the Morse’s function, a novel potential function with only three adjustable parameters per residue pair was developed, which will significantly increase the efficiency of protein structure prediction and molecular mechanics. Altogether, our studies have provided valuable information for the future caspase-3 based drug development.
|
Page generated in 0.0643 seconds